BNIGF (Beroni Group) Net Margin %: -315.65% (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BNIGF Beroni Group Ltd BNIGF
4 GF Score
Price $0.01
View Full Analysis

What is Beroni Group Net Margin %?

Beroni Group BNIGF 4 Net Margin % is -315.65% as of Jun. 2024. GuruFocus rates BNIGF with a GF Score™ of 4/100.

Net margin is calculated as Net Income divided by its Revenue. Beroni Group's Net Income for the six months ended in Jun. 2024 was $-0.36 Mil. Beroni Group's Revenue for the six months ended in Jun. 2024 was $0.12 Mil. Therefore, Beroni Group's net margin for the quarter that ended in Jun. 2024 was -315.65%.

The historical rank and industry rank for Beroni Group's Net Margin % or its related term are showing as below:


BNIGF's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.48
* Ranked among companies with meaningful Net Margin % only.

Beroni Group  (OTCPK:BNIGF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Beroni Group Net Margin % Related Terms


Beroni Group Net Margin % Historical Data

* Premium members only.

The historical data trend for Beroni Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beroni Group Net Margin % Chart

Beroni Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -457.49 -544.12 -121.18 -1,263.34 -1,966.88

Beroni Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,460.95 -1,143.12 -1,009.21 -4,460.92 -315.65

BNIGF vs PNXP, CRYM, GCAN: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beroni Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beroni Group Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beroni Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Beroni Group's Net Margin % falls into.


BNIGF
4GF Score
Beroni Group Ltd BNIGF
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beroni Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Beroni Group's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-6.176/0.314
=-1,966.88 %

Beroni Group's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.363/0.115
=-315.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -315.65% mean?
Beroni Group (BNIGF) has a Net Margin % of -315.65% as of Jun. 2024. Net margin is the ratio of total net income to net sales. View historical data on Beroni Group and its competitors.
Is Beroni Group's Net Margin % too high?
Beroni Group's current Net Margin % is -315.65%. Overall, Beroni Group has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Beroni Group's Net Margin % compare to PNXP and CRYM?
Beroni Group's Net Margin % of -315.65% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.48, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Beroni Group and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beroni Group's current Net Margin % is -315.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beroni Group stock overvalued right now?
Beroni Group (BNIGF) has a current Net Margin % of -315.65%. The current Net Margin % is -315.65%. Beroni Group's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Beroni Group (BNIGF), the current Net Margin % is -315.65% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beroni Group Business Description

Address 175 Pitt Street, Level 16, Sydney, NSW, AUS, 2000
Beroni Group Ltd is an Australia based company engaged in the sales of smoking control product (NicoBloc), air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics and viral diagnostic kits and also investing in the research and development of oncology drugs and therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Geographically, the company operates in China.
4GF Score

Get the complete analysis for BNIGF

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price